If the patient has a PFO discovered on TOE after randomisation, are they able to remain in the trial?

 In

Yes, they are permitted to stay in the trial.

What is the process if the patient is unable to write with regards to consent?
If a patient has a dilated left atrium but no thrombus on TTE – is this an exclusion criteria?